The trading price of ProQR Therapeutics N.V (NASDAQ:PRQR) closed higher on Friday, May 02, and closing at $1.99, 15.70% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $1.73 and $2.0. In examining the 52-week price action we see that the stock hit a 52-week high of $4.62 and a 52-week low of $1.07. Over the past month, the stock has gained 45.26% in value.
ProQR Therapeutics N.V, whose market valuation is $209.37 million at the time of this writing, is expected to release its quarterly earnings report on 2025-Mar-12. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.16 per share this quarter, however they have predicted annual earnings per share of -0.67 for current year and 0 for next year.
From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 19.26M.
On the technical side, indicators suggest PRQR has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned PRQR a recommendation rating is 5. Out of them, 1 rate it a Hold, while 4 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged ProQR Therapeutics N.V (PRQR) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that PRQR’s price is currently 46.27% off the SMA20 and 21.65% off the SMA50. The RSI metric on the 14-day chart is currently showing 72.71, and weekly volatility stands at 10.61%. When measured over the past 30 days, the indicator reaches 11.46%. ProQR Therapeutics N.V (NASDAQ:PRQR)’s beta value is currently sitting at 0.34, while the Average True Range indicator is currently displaying 0.14. With analysts defining $2-$5 as the low and high price targets, we arrive at a consensus price target of $3.75 for the trailing 12-month period. The current price is about -0.5% off the estimated low and -151.26% off the forecast high, based on this estimate. Investors will be thrilled if PRQR’s share price rises to $3.75, which is the median consensus price. At that level, PRQR’s share price would be -88.44% below current price.
To see how ProQR Therapeutics N.V stock has been performing in comparison to its peers in the industry, here are the numbers: PRQR stock’s performance was 15.70% in the latest trading, and 2.58% in the past year.
An evaluation of the daily trading volume of ProQR Therapeutics N.V (NASDAQ:PRQR) indicates that the 3-month average is 558.31K. However, this figure has increased over the past 10 days to an average of 0.75.
Currently, records show that 102.71 million of the company’s shares remain outstanding. The insiders hold 32.74% of outstanding shares, whereasinstitutions hold 42.88%. The stats also highlight that short interest as of 2025-04-15, stood at 0.83 million shares, resulting in a short ratio of 1.12 at that time. From this, we can conclude that short interest is 110.00 of the company’s total outstanding shares. It is noteworthy that short shares in April were down slightly from the previous month’s figure, which was 1.02 million. However, since the stock’s price has seen -24.91% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
